Mucociliary Clearance, Airway Inflammation and Nasal Symptoms in Urban Motorcycle-drivers
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sao Paulo, Brazil, 1246-903
- Faculdade de Medicina da Universidade de Sao Paulo
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil
- Universidade Federal de Minas Gerais
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Professional motorcyclists aged 18 years to 45 years
- Agreement with the written informed consent
Exclusion Criteria:
- inability to understand and to follow commands,
- previous nasal surgery,
- respiratory infection in the previous 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: saline and sniffing
This RRC is the combination of positioning (laying down), sniffing (only one side), throat vibration and saline instillation.
And then the other side.
|
This technique is a combination of positioning (laying down), saline instilation (5 ml in each side), sniffing (the side that received saline instilation) and throat vibration.
Then the other side.
|
|
Placebo Comparator: sniffing
Pacient will be in a lay down condition and will perform sniffing with throat vibration several times each side (but with no saline instillation)
|
This technique is a combination of positioning (laying down), sniffing (the side that received saline instilation) and throat vibration.
Then the other side.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nasal mucociliary clearance
Time Frame: 15 days
|
Saccharine transit time test.
|
15 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mucus physical properties
Time Frame: 15 days
|
Contact angle
|
15 days
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Upper airway symptoms
Time Frame: 15 days
|
Sinonasal Outcome Questionnaire -20
|
15 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Paulo HN Saldiva, PhD, University of Sao Paulo
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CEP-FMUSP 221/11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.